Conclusion: The findings suggest that the presence of anti-Sm, anti-Ro, and anti-RNP antibodies is associated with a higher risk of early LN development, specifically within five years after initial SLE diagnosis. The gene discussed is CALR; the disease is systemic lupus erythematosus.